Keynote: Tomorrow's NHS without NHS England - What is the future for Pharma?
Through the eyes of a former NICE insider; a 30,000-foot full-throttle take on the collapse of NHS England's structure – and the ripple effects across commissioning, VPAG, NICE, ICBs and pharma's next move.
Omar Ali discusses the critical role of payer insights in the pharmaceutical and medtech industries, drawing from his extensive experience in payer roles and his work with NICE. He highlights the importance of understanding payer perspectives, especially in light of recent changes in NHS structures and reimbursement processes. Ali emphasizes the shift from sales to access and usage, predicting that pharma and medtech will need to adapt to new neighborhood team dynamics and focus on offering system-wide solutions. He also notes the growing significance of value-based procurement and the necessity for flexible contracting in future negotiations. The presentation concludes with a call for collaboration and a focus on proving product effectiveness to justify premium pricing.
Presented live at the BHBIA Annual Conference 2025, Wembley Park, England
Disclaimer: This presentation is for discussion purposes only, and is not intended as legal or policy advice. This presentation is based on non-confidential intelligence. Views expressed by the speakers are personal opinions and should not be attributed to anyone else. No part of this video may be reproduced for commercial purposes without the express permission of Verpora.